Kim Peder Dalhoff

Kim Peder Dalhoff serves as a Clinical Professor within the Department of Clinical Medicine at the Faculty of Health and Medical Sciences, University of Copenhagen. His academic work focuses on clinical pharmacology with specialized expertise in cardiovascular drug effects, steroid research, and oncology pharmacology.

His research interests encompass several critical areas in modern medicine:

• Clinical Pharmacology and Toxicology
• Cardiovascular Disease and Drug Interactions
• Anabolic Androgenic Steroid Effects
• Oncology Pharmacology (particularly breast cancer and leukemia treatments)
• Drug Safety and Adverse Effects Monitoring
• Pharmacovigilance in chronic disease management

Professor Dalhoff's scholarly output demonstrates a consistent focus on medication safety and clinical outcomes across diverse patient populations. His research methodology frequently employs large-scale register studies and systematic reviews to generate evidence-based insights into drug effects. His work bridges clinical practice with pharmaceutical research, examining real-world medication impacts on patient health outcomes.

His publications appear in high-impact medical journals including Circulation, The Lancet Oncology, Haematologica, and European Journal of Epidemiology. These works have received significant attention across academic and public spheres, with multiple publications being featured in news outlets and widely shared on social media platforms.

Professor Dalhoff maintains active collaborations across multiple Danish institutions and internationally, contributing to research that addresses critical questions in medication safety and effectiveness across various disease states.